Aerin Medical Raises $16.7M to Back Radiofrequency Device Aimed at Remodeling Nasal Tissue

Fierce Medical Devices reported that Aerin Medical has raised $16.7 million in hopes to offer a novel non-invasive approach–the use of non-ablative radiofrequency energy to target and remodel nasal tissues to treat breathing orders caused by anatomical obstruction and mucosal dysfunction.
According to the article:

The only trial listed in ClinicalTrials.gov for Aerin Medical is a 33-patient pilot trial that was slated to have results primary endpoint data due earlier this year in January. In that single-arm trial, which is scheduled to wrap up in April, the InFlux System was used in patients with nasal airway obstruction. It used thermal coagulation of tissue in the nasal airway to accomplish that task.

According to Aerin CEO Fred Dinger:

Our non-invasive treatments are well suited to bridge the enormous gap between medical management and surgical interventions for this very large group of patients.

Click here to view the full press release.